EVIDENCE OF SUPPRESSOR CELL ACTIVITY IN SPLEENS OF MICE BEARING PRIMARY TUMORS INDUCED BY MOLONEY SARCOMA VIRUS by Kirchner, H. et al.
EVIDENCE  OF  SUPPRESSOR  CELL  ACTIVITY  IN  SPLEENS 
OF  MICE  BEARING  PRIMARY  TUMORS  INDUCED  BY 
MOLONEY  SARCOMA VIRUS* 
BY H.  KIRCHNER, T.  M.  CHUSED, R. B.  HERBERMAN, 
H.  T.  HOLDEN,:~ A~D D.  H. LAVRIN 
(From the National Cancer Institute, the National Institute of Dental Research, 
and Litton Bionetics,  Inc., Bethesda, Maryland 20014) 
(Received for publication 7 February 1974) 
According to the immune surveillance theory, tumors may arise because of a defect 
in the immune system (1, 2). Indeed, there are situations in which immunosuppression 
leads to an increased incidence of neoplasia. However, in most cases in which defects 
of the immune system have been noted in patients  and  animals with  spontaneous 
tumors, it is impossible to decide whether these are secondary in nature rather than 
preceding tumor development. It therefore seems of considerable interest  to perform 
functional analyses of lymphocytes in well characterized experimental tumor systems 
in order to better define alterations of the immune system, associated with the develop- 
ment of tumors.  These  studies  may detect  two  types  of  defects:  those  preceding 
tumor development, and those accompanying their growth. The latter,  although not 
providing support for the major tenet of the immune surveillance theory, may have 
considerable  relevance  to  the  crucial problem  of  tumor  immunology as  to  why  a 
growing tumor cannot be rejected despite the recognition of tumor-associated antigens 
(see reviews of these problems in references 3-6). 
We  have  initiated  a  series  of experiments  where  a  variety  of lymphocyte 
functions  are  analysed  during  the  ontogeny of murine  tumors  (references  7 
and  8,  and  footnote  1).  Functional  tests  of  immunity  to  tumor-associated 
antigens  were  applied,  as  well  as  tests  of  general  immunocompetence.  The 
latter seem to be able to unravel  additional  alterations  of the immune system 
of tumor-bearing  hosts,  which  cannot  be  detected  with  ease  by  the  specific 
assays  of  tumor  immunity.  The  in  vitro  stimulation  by  mitogens,  such  as 
phytohemagglutinin  (PHA), 2 has  proven  useful  for  evaluating  reactivity  of 
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lymphocytes  in  patients  with  malignancies  and  animals  with  experimental 
tumors  (9-13).  We  and  others  have  recently  observed  a  markedly  depressed 
PHA  response  in  spleens  of  mice  carrying  Moloney  sarcoma  virus  (MSV)- 
induced  tumors  (8,  14),  and have suggested that  this is not an intrinsic defect 
of the PHA  responsive T  cells, but  rather  may  be due  to a  suppressive  effect 
by  another  cell.  In  the  present  investigation  we  have  combined  a  number  of 
experimental  approaches  which  indeed  demonstrate  that  activation  of  such 
suppressor  cells occurs in MSV spleens, a 
Materials and Methods 
Animals and Tumor Systems.--C57BL/6N  (B6)  and Balb/C mice were obtained from the 
Division of Research Services, NIH, Bethesda, Md. Primary MSV tumors were induced by 
intramuscular  injection of 0.05 ml of MSV into  the right hind  leg of  10- to 14-wk  old B6 
mice, as previously described in detail (7). In this system tumors reach a maximum size be- 
tween 12 and 16 days after virus inoculation and then usually regress after 21 days. All experi- 
ments of this study were performed between  12  and  16 days.  In selected experiments two 
additional tumor systems were used. In one of these, tumors were induced by intramuscular 
injection of a variant of the MSV (Gz-MSV(M)) which causes progressively growing tumors 
in adult B6 mice. Dr. A. Gazdar, NIH, kindly provided this virus, the biological characteristics 
of which will be described elsewhere. Spleens of these mice were serially tested at intervals of 
5 days during the entire course of tumor development. In addition, the RBL-5 lymphoma of 
B6 mice  (15) was  utilized,  a  Rauscher  leukemia virus-induced ascitic tumor.  It had  been 
maintained in serial passage for many years and killed B6 mice within 15-20 days.  Spleens 
of these were investigated 7-10 days after intraperitoneal tumor cell injection. Nude (nu/nu) 
mice which had gone through 2-3 backcross generations with Balb/C  mice, were obtained 
through the courtesy of Dr. Carl Hansen, Division of Research Services,  NIH. 
In  Vitro Lymphocyte Culture Technique.--Spleens, and  in  some  instances  lymph  nodes 
(LN), were aseptically removed. Axillary and  inguinal LN  from  normal  mice were pooled, 
while from MSV tumor-bearing mice, draining right inguinal and lumbar  nodes were investi- 
gated separately from nondraining left axillary nodes.  Single cell suspensions  were made in 
medium RPMI 1640, supplemented with 100/zg/ml streptomycin, 100 U/ml penicillin, 2 mM 
glutamine, and 5% of fetal bovine serum (all reagents obtained from Grand Island Biological 
Co., Grand Island, N. Y.). A vol of 0.2  ml, containing 6  X  105 cells were cultured in each 
well of tissue culture-treated U plates  (Cooke Laboratory Products,  Cooke Engineering Co., 
Alexandria, Va.)  at 37°C  in an atmosphere  of 5% CO2 and 95% air.  For determination  of 
"spontaneous"  (mitogen-independent)  DNA synthesis,  spleen cells were cultured  for  16  h 
immediately after their removal with 5 #Ci/ml [~H]thymidine  (TdRH3)  (sp act 6 Ci/mmol; 
Schwarz/Mann Div., Becton, Dickinson & Co., Orangeburg,  N. Y.). 
Routinely, several PHA doses  (Burroughs Wellcome, Beckenham,  England)  were tested 
in each experiment. Under all conditions tested here, the dose responses  of MSV animals were 
similar to those of normal animals. Therefore, only results obtained with optimal PHA doses 
(1 #g/ml) are included in most of the tables. In these experiments cultures were incubated 
for 48 h, after which TdRH3 was added for another  16-18  h. Cultures were harvested by a 
multiple-automated  sample  harvester  (Microbiological Associates,  Inc.,  Bethesda,  Md.)  on 
glass fiber filters. These were taken up in Aquasol  a  (New England Nuclear, Boston, Mass.) 
and counted in a liquid scintillation counter. The results are expressed as mean cpm of tripli- 
cate samples. The standard errors of this assay are 5-10~ and are subsequently not included 
in the tables. 
3 For brevity, spleens from mice carrying primary MSV-induced tumors,  12-16 days after 
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Rayon Adherence Columns.--Two large  size rayon  balls  (Parke  Davis  &  Co.,  Detroit, 
Mich.) were packed into 12-ml  syringes (Monoject, Sherwood Medical, Industries, Inc., De- 
land~ Fla.). These were autoclaved and washed with 50 ml of balanced salt solution. About 
10  s spleen ceils in 7 ml of complete RPMI  1640 medium (GIBCO) were incubated for  15-20 
min on these columns at room temperature  and  then slowly eluted.  About 20-25%  of the 
original cell population were recovered from these columns.  Preliminary investigations have 
demonstrated  the presence of functionally intact B and T lymphocytes in the column eluates, 
but phagocytic ceils were effectively eliminated. 
Treatment of Spleen Cells with Carbonyl Iron and Magnet.--Lymphocyte separating agent, 
containing earbonyl iron particles, was obtained from Technicon Instruments Corp., Tarry- 
town, N. Y. 3-5 X  107 spleen cells were suspended in 7 ml of this reagent and incubated for 
60 rain at 37°C in conical 50-ml tubes  (Falcon Plastics, Div. of BioQuest, Oxnard,  Calif.). 
The tubes were then put on top of a magnet and the supernate removed by Pasteur pipettes. 
This procedure was repeated 6-8 times and the cells were washed once before cultivation. 
Treatment by Anti-O Serum.--Anti-O serum was produced in AKR mice by a  procedure 
identical to that used by Reif and Alien (16). Treatment with this antiserum plus guinea pig 
complement (C') has been previously shown to completely eliminate stimulation of B6 spleen 
cells by PHA and concanavalin A, while it did not affect the proliferative response to bacterial 
lipopolysaecharide  (endotoxin)  (LPS)  (17). Spleen cells were incubated  with anti-0 for 45 
rain  at 0°C, washed,  and  resuspended  in  1:3 diluted  guinea pig C'  (Texas Biological Co., 
Fort Worth, Texas) for 30 min at 37°C.  Control spleen cell suspensions  were treated with C' 
alone. 
Treatment of Spleen Cells by Bromodeoxyuridine.--Single cell suspensions  of normal  or 
MSV spleens  in  RPMI  1640  (GIBCO)  were  prepared  as  usual.  5-bromo-2'-deoxyuridine 
(BUDR)  (Schwarz/Mann Div., Becton, Dickinson & Co.) was added at a concentration of 
30/~g/ml, and the cells were cultured in 16 X  125-mm plastic  tubes (Falcon Plastics, Div. of 
BioQuest) for about 6 h  (total vol 3 ml, cell density 1 X  10 s ml). They were then illuminated, 
as described by Zoschke and Bach (18), washed three times, and resuspended in medium. 
51Cr-Rdease Assay of Cellular Cytotoxicity.--The method of measuring cytotoxicity of MSV 
spleen cells against  RBL-5 ascitic lymphoma cells,  has  been described in detail  previously 
(7). Briefly, 107 spleen cells were incubated for 4 h with 5 X  104  51Cr-labeled target cells in 
35  X  10-mm plastic petri dishes on a  rocking platform. The background  nlCr release was 
determined by incubation of the S'lCr-labeled target ceils with  unlabeled target cells.  Experi- 
mental results were expressed as the percent lysis in the experimental group minus the back- 
ground lysis. 
Primary In ~itro Immune Response to Sheep Red Blood Cells (SRBC).--The  technique of 
Mishell and Dutton (19) was followed with minor modifications. Briefly, 107 spleen ceils were 
cultured in 1.0 ml of Eagle's minimal essential medium (GIBCO) plus 10% fetal bovine serum 
in 35 X  10-ram plastic petri dishes (Falcon Plastics, Div. of BioQuest). They were incubated 
for 4 days on a rocking platform in an atmosphere of 10% CO2, 10% O2, and 80% N2. SRBC 
were added at a  concentration of I07/ml and after 4 days plaque-forming cells (PFC) were 
enumerated by the technique of Cmnningham  and Szenberg (20).  All assays were performed 
in triplicate. 
RESULTS 
Some  Characteristics  of  Spleens from  MSV  Tumor-Bearing  Mice.--MSV 
spleens were considerably enlarged and contained  three  to four times as many 
higher numbers  of mononuclear cells than spleens from normal  controls  (Table 
I). The T-cell population,  as estimated by the number  of cells killed by anti-0 
serum plus  C'  was  about  5-10%  lower in  MSV  spleens  than  in  controls.  The 
number of phagocytic cells was increased about threefold in spleens from tumor- 
bearing  mice.  The  TdRH3  uptake  of MSV  spleen  cell cultures  on  a  per  cell 1476  SUPPRESSOR CELLS IN THE MSV  TIY~OR SYSTEM 
basis was increased  8-10 times when measured during  the first  16 h  after  re- 
moval  of the spleens  and  compared with spleens  from normal  B6 mice. This 
elevated  "spontaneous"  (mitogen-independent)  DNA  synthesis  was  reduced 
to normal values  when  MSV  spleen  cells  were  treated  by passage  through  a 
rayon adherence column. It was reduced by 70 %  when MSV spleen cells were 
incubated  with  iron particles  and  subsequently  exposed  to  a  magnet  (Table 
II). However, it  was not reduced after  treatment  with  anti-0  serum plus  C'. 
The low  spontaneous  DNA synthesis  of normal  spleens  was  also  reduced  to 
some extent by the adherence columns and the iron magnet technique, but was 
not affected by anti-0 treatment. 
PttA  Response of Spleen and Lymph Node Cells from MSV  Tumor-Bearing 
Mice.--The  PHA response of MSV spleen  cells was strongly depressed  at  all 
mitogen doses.  In some experiments  almost no  response  was  seen  (as in  the 
experiment shown in Table III). In others, the response was decreased 80--90 %, 
when compared with matched control mice (Tables IV and V). When the PHA 
response of pooled LN lymphocytes from normal and MSV mice were compared, 
TABLE I 
Some Characteristics of Spleens  from B6 Mice with Primary MSV-Induced  Tumors, 14 Days 
after Virus Inoculation 
MSV spleen  Normal spleen 
Weight*  278.3 mg  73.4 mg 
No. of mononuclear cells*  2.82  X  10  s  0.76  X  108 
Percentage  of macrophages§  10.2  3.5 
Percentage  of T cells§  25.3  32.7 
DNA synthesis/10e  cells[]  42,480 cpm  4,328 cpm 
* Measured immediately after removal, mean of 10 mice. 
:~ Determined after phagocytosis of latex particles. 
§ Number of cells, killed by anti-0 serum plus C' (trypan blue exclusion test), mean of five 
experiments. 
[[ TdRH3 incorporation during the first 18 h after spleen removal (no mitogen was added), 
mean cpm of five experiments. 
TABLE  II 
Effect o/Various Treatments on TdRIt3 Uptake of Spleen Cells/tom MSV Tumor-Bearing and 
Normal B6 Mice 
Treatment before culture  MSV spleen  Normal spleen 
None  22,319"  2,625 
Eluate from rayon column  718  818 
Iron/magnet  4,918  648 
Anti-0 plus C'  18,408  2,643 
* Mean cpm of triplicate cultures of 6 X 105 cells; TdRH3 incorporation during the first 18 
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TABLE  III 
PHA Stimulation  of Spleen and LN Lymphocytes from MSV Tumor-Bearing Mice 
Source  of Cells 
Dose of PHA (vg/ml) 
None  5  2.5  1.25 
I 
MSVspleen  5,749*  3,848  8,271  9,115 
Normal spleen  1,842  72,894  84,952  126,297 
MSV pooled LN  4,968  23,174  53,294  33,843 
Normal pooled LN  1,320  140,612  88,432  80,212 
II 
MSV draining  LN  14,507  17,412  16,596  13,842 
MSV distal LN  6,603  80,504  49,730  17,826 
Normal pooled LN  304  120,801  74,203  53,288 
* Mean TdRH3 uptake of triplicate cultures at 72 h after a  16 h pulse of isotope, the SE 
of this assay is always < 10% and not included in the tables. 
TABLE IV 
Comparison of Specific Cytotoxicity and  PItA  Responsiveness of Spleen  Cells from  B6  Mice 
Carrying Three Different Types of Tumors 
Tumor system  PHA stimulation  Cytotoxicity* 
c~n  % 
Standard  MSV  16,342  29.6 
Gz-MSV(M)  14~  12,442  22.7 
Gz-MSV(M) 28,  14,812  3.6 
RBL-5§  10,837  4.1 
Normal B6  98,712  2.3 
* As determined by  51Cr release from syngeneic ascitic RBL-5 lymphoma cells in a  4 h 
assay. 
Gz-MSV(M)-induced, progressively growing tumors 14 and 28 days after inoculation. 
§ Spleens from B6 mice carrying the ascitic lymphoma RBL-5  7 days after tumor cell 
inoculation. 
TABLE V 
Restoration of PHA Reactivity of MSV Spleen Cells by Rayon Adherence Columns and Iron~ 
Magnet Treatment 
Source of cells 
Treatment 
PHA  None  Column  Iron/Magnet 
MSV spleen  --  4,370*  1,314  2,623 
+  20,167  84,450  61,330 
Normal B6 spleen  --  3,655  589  620 
+  92,633  107,405  69,627 
* Mean cpm of triplicate cultures of 6 X  105 cells. 1478  SUPPRESSOR  CELLS  IN  THE  MSV  TUMOR  'SYSTEM 
a  defect was also observed. However, this defect was more marked when LN 
draining  the  tumor site  were  studied  separately.  The  two  primary draining 
LN,  the  right  inguinal  and  lumbar  nodes  are  usually  much  larger  than  the 
contralateral nodes and are easily identifiable.  Lymphocytes from these were 
almost  totally unresponsive,  while  cells from the  distal  LN  revealed a  PHA 
response closer to the reactivity of normal pooled LN lymphocytes (Table III). 
Correlation Between PHA  Responsiveness and Specific Cytotoxicity of MSV 
Spleens.--Specific  cytotoxicity of MSV spleen cells against syngeneic lymphoma 
cells  was  measured  in  a  5ZCr-release  assay.  An  inverse  relationship  between 
the development of cytotoxic effector cells in MSV spleens and the depression 
of  the  PHA  response  was  consistently  observed  (Fig.  1).  Cytotoxicity  and 
PHA responsiveness were also compared in two additional  tumor systems. In 
spleens  from mice  carrying  the  RBL-5  leukemia  in  ascitic  form,  the  PHA 
response was strongly suppressed,  and  there  was only low cytotoxic activity 
(Table  IV).  B6  mice,  injected  with  Gz-MSV(M)  demonstrated  appreciable 
specific cytotoxicity only during  the first 21  days. Later in  the  course of the 
progressively growing  tumor,  only low  levels  of  cytotoxic activity  could  be 
demonstrated. In contrast, the PHA response was defective through the entire 
growth period of the tumor. 
Reconstitution of the PHA Response of MS V Spleen Cells by Adherence Columns 
or by Iron/Magnet  Treatment.--The  defective PHA  response  of MSV  spleen 
cells could be restored by passage of the cells through rayon adherence columns 
before  PHA  stimulation  (Table V).  The proportion  of  the  total  spleen  cell 
IOO  40 
Js0 
3o>. 
¢r  }_ 
o 
Z 
U.  60  X 
o  ~o 
m~  o 




3  6  9  12  15  18  21 
DAYS AFTER INOCULATION OF MSV 
FIC.  1.  Correlation between the development of specific cytotoxicity (A--A)  and  the 
depression of the PHA response (Q--Q) in spleens of B6 mice bearing primary MSV-induced 
tumors. Cytotoxicity was determined by the percentage 51Cr release from syngeneic  lymphoma 
cells and PHA reactivity is expressed as the percent of TdRH3  uptake  of simultaneously 
tested normal PHA-stimulated cultures. KLRCHNER, CHUSED, HERBERMAN, HOLDEN, AND LAVRIN  1479 
population  removed by this  type of column was similar  in normal  and MSV 
spleens  (70-80%).  However,  column  treatment  caused  only a  small  increase 
in TdRH3 uptake of PHA-stimulated normal spleen cells at the cell densities 
we have used in our experiments.  Mixing of column-purified MSV spleen cells 
with unseparated isogeneic spleen cells reduced the PHA response to the level 
seen before column treatment  (Table VI). 
Spleen  cells  were  also  incubated  with  carbonyl  iron  particles  and  treated 
by a  magnet.  This  treatment  removed about  30%  of the  cell  population  of 
both normal and MSV spleens. It led to an increase of PHA reactivity of MSV 
spleen cell cultures comparable to that observed after column treatment (Table 
V). 
Inhibitory Effect of MSV Spleen Cells on the PHA Response of Normal Spleen 
Cells.--The above experiments suggested a possible role of a  suppressor cell in 
the inhibition of the PHA response. To directly demonstrate such an activity, 
MSV spleen  cells  were mixed with syngeneic normal spleen  cells before PHA 
was added.  In these experiments  the fixed number of normal spleen  ceils was 
6  X  10  5 and various numbers of MSV spleen cells were added. A  suppressive 
effect on the PHA response of normal spleen cells could be demonstrated when 
2 ×  10 5 or more MSV spleen cells were added (Table VII). Admixture of addi- 
tional normal spleen cells had no inhibitory effect. Similarly, spleen cells from 
TABLE VI 
Mixing  of Cdumn-Purified MSV Spleen Cells with Autologous-Unpurified Spleen Cells 
No mitogen  PHA 
A  Unpurified MSV spleen  4,841  8,920 
B  Column-purified MSV spleen  3,152  110,001 
C  A and B at a 1:1 ratio  5,582  10,004 
D  Unpurified normal spleen  2,820  88,412 
E  Column-purified normal spleen  1,213  106,412 
F  D and E at a 1:1 ratio  1,923  112,418 
TABLE VII 
Inhibitory Effect of MSV Spleen Cells on the PHA Response of Spleen Cells  from Syngeneic 
Normal Mice 
Source and no. of Cells  No mitogen  PHA 
6  X  105 normal spleen cells 
6  X  105 MSV spleen ceils 
6  X  10 5 normal and 4 X  105 MSV 
6  X  10 5 normal and 2 X  105 MSV 
10  X  105 normal spleen cells 
8  X  105 normal spleen cells 
1,354  77,321 
2,870  18,342 
3,330  24,330 
3,140  29,340 
2,640  104,328 
2,349 ~  93,480 
Before being placed in culture various numbers of MSV spleen cells or normal spleen cells 
were added to a fixed number of normal spleen cells (6 X 105). 1480  SUPPRESSOR  CELLS  IN  THE  MSV  TUMOR  SYSTEM 
B6  mice  after  regression  of  MSV  tumors  were  ineffective.  The  suppressor 
activity of MSV  spleen cells was eliminated after passage through adherence 
columns  and  treatment  by the  iron/magnet  technique  (Table VIII). It was 
unaffected by treatment with anti-0 plus C'. 
Effect of Pretreatment by BUDR on the PttA Response of MSV Spleen Cells.-- 
A  comparison between  the  experiments of Table II and Table VIII showed 
that the techniques which remove cells synthesizing DNA from MSV spleens, 
also abolished the suppressive capacity of this population, suggesting that the 
suppressor cell is a proliferating cell.  Further evidence for this assumption was 
obtained by pretreatment  of~ MSV  spleen cells with  BUDR,  which  has been 
recently shown to selectively inactivate DNA-synthesizing cells in cultures of 
lymphoid cells  (18).  MSV  spleen cells were treated with  BUDR for 6  h  and 
extensively washed before addition of PHA. In this experiment, BUDR-treated 
MSV spleen cells demonstrated a significantly higher (about threefold) TdRH3 
uptake after PHA stimulation than did cultures of untreated MSV spleen cells 
(Table  IX).  In  contrast,  preincubation  with  BUDR  caused  no  increase  of 
PHA reactivity of normal spleen cells. 
Lack of Suppressive Activity by Spleen Cells from Nude Mice and Spleen Cells 
Treated with Anti-O Serum--Spleen  cells from nude mice, shown  to be totally 
unresponsive to PHA, were added to normal Balb/C spleen cells before addition 
of  PHA.  These  nude  mice  had  gone  through  several  backcross  generations 
TABLE  VIII 
Effect of Various Treatments of MSV Spleen Ce~Is  on Their Ability to Suppress the PItA Response 
oJ Normal Spleen Celts 
Treatment*  Normal spleen cells  Normal and MSV spleen calls 
None  93,831  16,378 
Anti 0 and C'  --  18,744 
Rayon column  --  84,314 
Iron/magnet  --  68,412 
* 3 X 105 MSV spleen cells, treated by various methods were added to 6 X 105 normal B6 
spleen cells before the addition of PHA. 
TABLE IX 
Effect of Pretreatment with BUDR on the PHA Response of Normal and MSV Spleen Cells 
Source of s~een cells  BUDR  No mitogen  PHA 
MSV  --  6,340  22,112 
+  1,814  63,120 
Normal  --  1,733  78,214 
+  833  72,319 
Spleen cells were incubated for 6 h with or without 30 #g/ml of BUDR, illuminated and 
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with Balb/C, but were not syngeneic. This accounts for the observed low grade 
mixed leukocyte reaction (Table X). The PHA response of Balb/C spleen cells 
remained unaltered after addition of nude spleen cells, Normal B6 spleen cells, 
unreactive to PHA after treatment with anti-0 plus C' were also ineffective in 
inhibiting  the  PHA response  of syngeneic untreated  spleen  cells  (Table  XI). 
These two experiments show that it requires more than just dilution by PHA 
unreactive spleen cells to inhibit the PHA response of normally reactive spleen 
cells. 
Primary In  Vitro Immune Response of MSV  Spleen Cells to SRBC.--To  test 
another  lymphocyte function in  addition  to  the  PHA  response,  the  primary 
in vitro antibody response of MSV spleen cells to SRBC was also investigated. 
After  4  days  in  culture  spleen  cells  from  tumor-bearing  mice produced  less 
than 10 %  the number of PFC produced by normal controls (Table XII). This 
TABLE X 
Effect of Spleen Cells  from Nude Mice on the PHA Response of Balb/C Spleen Cells 
Source of cells  No mitogen  PHA 
6  X  105 Balb/C spleen cells  1,843  136,321 
6  X  105 nude spleen cells  2,241  2,333 
6  X  105 Balb/C and 3 X  105 nude spleen cells  7,347*  129,453 
* Nude mice had been backcrossed with  Balb/C mice but were not syngeneic, a mixed 
leukocyte reaction was therefore observed. 
TABLE XI 
Effect of Anti-O-Treated Spleen Cells on the PHA  Response of Syngeneic B6 Spleen  Cells 
Cells added to 6 X  10~ B6 spleen cells  No mitogen  PHA 
None  1,120  86,315 
4  X  105 spleen cells treated by C' alone  2,370  115,368 
4  X  105 spleen cells treated  with anti-0 and C'  3,839  89,348 
6  X  105 C'-treated spleen cells alone 
6  X  105 anti-0 and C'-treated cells alone 
2,241  121,340 
1,873  2,245 
TABLE XII 
In Vitro Response to SRBC of Spleen Lymphocytes from Normal B6 and MSV Tumor-Bearing 
Mice 
Source of cells  SRBC  Plaque-forming  cells per culture 
Normal spleen  --  71  (32-253)* 
q-  4,051  (3,376-4,871) 
MSV spleen  --  11  (3-39) 
+  57  (18-178) 
* Geometric means and 67% confidence limits of four pooled experiments. 1482  SUPPRESSOR  CELLS  IN  THE  MSV  TUMOR  SYSTEM 
defect could not be restored by the addition of 2-mercaptoethanol (data not 
shown). The recovery of viable cells in normal controls was about 40 %, while 
in MSV spleen cells it was about 30 %. This difference in cell survival cannot 
account for the inability of MSV spleen cells to mount an immune response to 
SRBC,  since at  a  survival rate of 30%  the normal  spleen cells still  respond 
almost normally. 
DISCUSSION 
There is considerable controversy as  to whether the presence of a  tumor 
leads to depression or stimulation of the immune system. Spleens  and draining 
LN  of  mice with methylcholanthrene-induced transplanted  tumors show 
morphological signs of activation and elevated DNA synthesis (12, 21). With 
the use of discontinuous albumin density gradients, changes in these spleens 
have been demonstrated,  similar to those seen after immunization with SRBC 
(12).  In contrast, numerous studies  (for review see references 4  and 5)  have 
shown marked deficiencies in the cellular immune response of tumor-bearing 
patients  and  of experimental animals.  Signs of splenic activation,  similar to 
those described above, were seen in our study using B6 mice carrying primary 
MSV-induced  tumors.  These  spleens  were  considerably  enlarged,  contained 
four times the normal number of mononuclear cells,  and displayed markedly 
elevated DNA  synthesis  on a  per  cell  basis.  Similar  observations were  also 
made in LN draining the site of the MSV tumor. 
However, the PHA  responses of these spleens and LN on a  per cell basis 
were strongly suppressed. This defect was reversed by adherence column treat- 
ment,  and  by treatment  with  iron  plus  magnet,  a  technique  which  mainly 
removes phagocytic cells.  There are  several possible explanations for the re- 
constituting effects, obtained by these  techniques:  (a)  PHA  reactive T  cells 
in  MSV  spleens  are  simply diluted  out  by cells  unreactive to  PHA;  (b)  T 
lymphocytes of MSV spleens, rendered unreactive to PHA are altered by these 
techniques in  a  way that  restores their PHA  reactivity; and  (c)  Suppressor 
cells are present in MSV spleens, which suppress the in vitro PHA response, 
and these cells are removed by the column or by the iron/magnet treatment. 
All the data we have obtained in this study point toward the third of these 
possibilities. The activity of suppressor cells was directly demonstrated when 
MSV spleen cells were mixed with normal spleen cells before addition of PHA. 
Spleen  cells  from  nude  mice  and  syngeneic normal  spleen  cells  treated  by 
anti-0 and C', both totally unreactive to PHA, had no inhibitory effect. This 
demonstrates that  it requires more than just dilution by PHA  unresponsive 
cells to suppress the PHA response of normal spleen cells. 
The concept of suppressor cells regulating  the immune response has  been 
recently emphasized.  Several types  of suppressor  cells have  been  described. 
Thymic-derived suppressor cells (22-26) have been thought to regulate B-cell 
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proliferation of T cells have also been described. These have included peritoneal 
and alveolar macrophages (27), splenic macrophages (28), and adherent spleen 
cells, thought to be different from macrophages (29). The suppressor cell of the 
PHA response, which we have found in spleens of MSV tumor-bearing mice, 
has  the  following characteristics:  It  was  not  inactivated by treatment  with 
anti-8 plus C' and therefore appears to be not a T  lymphocyte. Since the sup- 
pressor cell was removed by the adherence columns and the iron/magnet tech- 
nique, it seems to be a cell of the monocyte/macrophage series. However, the 
magnet technique in our hands removes a larger percentage of spleen cells than 
are phagocytic by morphological criteria. It is therefore not possible to com- 
pletely rule out the possibility that the suppressor cell is for example an ad- 
herent subpopulation of B cells. 
We  have  found  that  the  same  techniques  that  abolished  the  suppressive 
effect of MSV spleen cells,  also greatly reduced their elevated "spontaneous" 
(mitogen-independent)  DNA  synthesis  (compare  Table  II  and  VIII).  It  is 
therefore possible  that  the  cells with  elevated DNA  synthesis  and  the  sup- 
pressor cells of the PHA response are identical. This was also suggested by our 
findings that BUDR treatment, before addition of PHA, resulted in a signifi- 
cant increase of PHA reactivity of MSV  spleen cells.  A  technique, selecting 
for cells in the DNA-synthesizing phase of the cell cycle (30) may therefore be 
suited to enrich suppressor cells. 
An  inverse relationship was  observed between the development of specific 
cytotoxic effector cells and the development of suppressor cells in the standard 
MSV system. Therefore, one may ask whether the cytotoxic effector cells and 
the suppressor cells are identical. However, the effector cell in the 51Cr-release 
assay of cytotoxicity has been previously shown to be a T  cell (31,  32), while 
the suppressor cell of the PHA response appears not to be a T  cell. Further- 
more, in related tumor systems  (Table IV)  a  strong depression of the  PHA 
response was seen in the absence of significant cytotoxicity. 
The mechanisms  that cause the development of suppressor cells in tumor- 
bearing mice are as yet not clearly understood. However, the depression of the 
PHA response in MSV spleens clearly paralleled the development of the tumor 
and was no longer demonstrable after tumor regression (8). It therefore seems 
likely that  the  tumor itself  releases  substances  that  are  transported  to  the 
spleen with resultant activation of suppressor cells.  The suppressor cells seem 
to have a somewhat selective effect on T-lymphocyte functions, since we have 
recently shown  that  the  response  of  MSV  spleen  cells  to  concanavalin  A, 
another T-cell mitogen (33), was depressed in a  similar manner as the PHA 
response (8). In contrast, the responses to LPS and pokeweed mitogen, both 
known  to  stimulate  murine  B  lymphocytes  (33,  34),  were  affected less.  In 
spleens of mice carrying the RBL-5 lymphoma in ascitic form, this was even 
more marked,  since we have observed completely normal  responses to LPS, 
at  a  time when PHA  reactivity was  maximally suppressed?  In  the present 1484  SUPPRESSOR  CELLS  IN  THE  MSV  TUMOR  SYSTEM 
investigation we have also found that the primary in vitro response to SRBC 
was  totally abolished in spleens of mice with MSV  tumors. This function is 
known to depend on a cooperation between B and T  cells (35), and in analogy 
with previous findings in another tumor system (36) one may assume that the 
defect observed in the MSV spleens is also primarily a defect of the helper T 
cell. 
Gorczynski has presented evidence that lymphocyte stimulation by tumor- 
associated antigens was similarly affected as the PHA response by suppressor 
cells (14). Tumor-associated immunity, measured by 51Cr release from syngeneic 
tumor cells,  seems to be unaffected by these suppressor cells.  Column purifica- 
tion which removed the suppressor cells of the PHA response, did not increase 
but moderately decreased the activity of MSV  spleen  cells in  the  Cr-release 
assay  of  specific  cytotoxicity.  4 Furthermore,  studies  now  in  progress  have 
shown that mitogen-induced cytotoxicity and 15Tnphocyte-induced antibody- 
dependent cytotoxicity are normal in MSV spleen cells. ~ Obviously, the sup- 
pressor  cell  we  have  described  only  affects  certain  aspects  of  lymphocyte 
reactivity, and further work is necessary to clarify the nature of this selectivity. 
There are  striking parallels  between our results in a  tumor system and  a 
recent report  (28)  on  the effects of infection with  Corynebacterium parvum 
and of a  graft-vs.-host reaction.  In both cases markedly depressed PHA  re- 
sponses were observed and activation of suppressor cells, supposed to be macro- 
phages, could be demonstrated. In another study of spleen cells undergoing a 
graft-vs.-host  reaction  (37),  a  depression  of  the  primary  in  vitro  antibody 
response to SRBC by suppressor cells was found, again paralleling our results 
in a virus-induced tumor system. The results of Gorczynski (14) and our study 
suggest that  the activation of suppressor cells  is an important feature in the 
alterations  of the immune  system induced by a  growing tumor. Tumors,  as 
repeatedly  observed,  induce  a  strong  activation  of  the  reticuloendothelial 
system. However, during  this  activation,  activation  of suppressor  cells also 
occurs, which then interferes with selected aspects of the immune response. It 
is conceivable that these suppressor cells also interfere with the immune reac- 
tion against the tumor itself. This hypothesis, however, needs further experi- 
mentation for support. 
SIYMMARY 
Spleens  from  Moloney  sarcoma  virus  (MSV)  tumor-bearing  C57BL/6N 
mice contained four times the normal  number of mononuclear cells and dis- 
played  a  markedly  elevated  "spontaneous"  (mitogen-independent)  DNA 
synthesis on a per cell basis. The number of macrophages were increased three- 
fold while  there was  a  slight reduction in the percentage of T  lymphocytes. 
The phytohemagglutinin (PHA)  response on a  per  cell basis of spleens from 
4 H. T. Holden and H. Kirchner, unpublished observations. 
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tumor-bearing mice was  decreased  about  90%  when  compared with  normal 
control mice. The primary in vitro immune response to sheep red blood cells 
was also suppressed to levels of less than  10 %  of normals. 
The PHA response could be restored by purification of MSV spleen cells by 
rayon  adherence  columns  and  by  removal  of  phagocytic  cells  by  an  iron/ 
magnet technique. The activity of suppressor cells in MSV spleens was demon- 
strated in mixtures with syngeneic normal spleen cells where a marked impair- 
ment of the  PHA response was  observed.  Spleen  cells from tumor-free nude 
mice and normal spleen cells treated by anti-0 serum plus guinea pig comple- 
ment (C'), both totally unreactive to PHA, had no such effect. The inhibitor 
cell in MSV spleens was shown to be insensitive to inactivation by anti-0 plus 
C',  but  could  be  removed  by  the  adherence  columns  and  the  iron/magnet 
technique.  These data suggest that this suppressor cell is a  cell of the mono- 
cyte/macrophage series.  Suggestive evidence was also presented that the sup- 
pressor cells belong to a proliferating population in MSV spleens. Similar sup- 
pressor  cells have been previously demonstrated  in  spleens of mice during  a 
variety of immune responses. Our data show, that a tumor, although stimulat- 
ing  the immune system, nevertheless may be suppressive on certain immune 
functions through the activation of suppressor cells. 
The authors are indebted to Dr. R. M. Gorczynski for providing a preprint of his paper 
(iS). 
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